CAR T cells for treating autoimmune diseases
Autoimmune disorders occur when immune cells go wrong and attack the body’s own tissues. Currently, autoimmune disorders are largely treated by broad immunosuppressive agents and blocking antibodies, which can manage the diseases but often are not curative. Thus, there is an urgent need for advanced...
Saved in:
Main Authors: | Dimitrios Mougiakakos, Ulrike Koehl, Stephan Fricke, Ulrich Blache, Sandy Tretbar |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-11-01
|
Series: | RMD Open |
Online Access: | https://rmdopen.bmj.com/content/9/4/e002907.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunotherapy Deriving from CAR-T Cell Treatment in Autoimmune Diseases
by: Yuehong Chen, et al.
Published: (2019-01-01) -
CAR T-cells to drive away autoimmunity in lupus
by: Sakir Ahmed
Published: (2019-01-01) -
B Cells in Autoimmune Diseases
by: Christiane S. Hampe
Published: (2012-01-01) -
Efficacy and safety of CAR-T cell therapy in B-ALL patients previously treated with blinatumomab
by: Yurou Chu, et al.
Published: (2025-02-01) -
T-regulatory cells for the treatment of autoimmune diseases
by: Marina S. Fisher, et al.
Published: (2025-02-01)